Showing results (1701-1710 of 1,933) with videos related to

Sort By:
Pageof 194
Journal of Thrombosis and Haemostasis : JTH|August 22, 2014
Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography-pulmonary angiographyJ Kooiman, Y W J Sijpkens, M van Buren, et al.
ESC Heart Failure|February 17, 2023
Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devicesLieke Numan, Daniel Zimpfer, Osnat Itzhaki Ben Zadok, et al.
British Journal of Clinical Pharmacology|March 11, 2015
Task analysis of information technology-mediated medication management in outpatient careF van Stiphout, J E F Zwart-van Rijkom, L A Maggio, et al.
European Urology Oncology|April 29, 2025
Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort AnalysisDebbie G J Robbrecht, Youssra Salhi, John W M Martens, et al.
Haematologica|December 7, 2022
Adipocytes control hematopoiesis and inflammation through CD40 signalingMyrthe E Reiche, Kikkie Poels, Laura A Bosmans, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2013
Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancerB E P J Vriens, M J B Aarts, B de Vries, et al.
Nature Medicine|December 11, 2021
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trialThomas Powles, Srikala S Sridhar, Yohann Loriot, et al.
The Journal of Frailty & Aging|April 1, 2016
Co-Presence of Multimorbidity and Disability with Frailty: An Examination of Heterogeneity in the Frail Older PopulationS Aarts, K V Patel, M E Garcia, et al.
Cardiovascular and Interventional Radiology|June 18, 2021
Predictive Factors for Hypertrophy of the Future Liver Remnant After Portal Vein Embolization: A Systematic ReviewE A Soykan, B M Aarts, M Lopez-Yurda, et al.
The British Journal of Dermatology|February 22, 2023
Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action studyKoen Dudink, Klasiena Bouwman, Yanqing Chen, et al.
Pageof 194